<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M531</article-id>
      <article-id pub-id-type="publisher-id">molbank-2007-M531</article-id>
      <article-categories>
        <subj-group>
          <subject>Short note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Synthesis of 2-[4-(2-chlorobenzyl)-3-methyl-6-oxopyridazin-1(6H)-yl]acetohydrazide</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Benchat</surname>
            <given-names>Nour-Eddine</given-names>
          </name>
          <xref rid="c1-molbank-2007-M531" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Anaflous</surname>
            <given-names>Abderrahmane</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Abouricha</surname>
            <given-names>Said</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>El-Bali</surname>
            <given-names>Brahim</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ramdani</surname>
            <given-names>Mohamed</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2007-M531">Department of Chemistry, University Mohamed I, Sciences Faculty, 60000 Oujda, Morocco</aff>
      <author-notes>
        <corresp id="c1-molbank-2007-M531"><label>*</label> Author to whom correspondence should be addressed. E-mail: <email>n_benchat@yahoo.fr</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>05</month>
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>05</month>
        <year>2007</year>
      </pub-date>
      <volume>2007</volume>
      <issue>2</issue>
      <elocation-id>M531</elocation-id>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>01</month>
          <year>2006</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>06</month>
          <year>2006</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2007 by MDPI (http://www.mdpi.org/).</copyright-statement>
        <copyright-year>2007</copyright-year>
        <license>
          <p>Reproduction is permitted for noncommercial purposes.</p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>pyridazin-3(2H)-one</kwd>
        <kwd>N-alkylation</kwd>
		<kwd>anticonvulsive agents</kwd>
	  </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>Pyridazines are of chemical and biological interest. They have been reported to be anticonvulsive agents [<xref ref-type="bibr" rid="B1-molbank-2007-M531">1</xref>], [<xref ref-type="bibr" rid="B2-molbank-2007-M531">2</xref>]. Furthermore, BELLASIO et al. have described the antihypertensive effects of hydrazinopyridazine compounds [<xref ref-type="bibr" rid="B3-molbank-2007-M531">3</xref>]. In continuation of this line of investigation, we have synthesized compound (I); it will be subjected to further pharmacological investigations, especially tests of its anticancer activity. </p>
	   <p>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M531-i001.tif"/>
      </p>
      <p>To ( 0.96 g, 3 mmol) of ethyl [4-(2-chlorobenzyl)-3-methyl-6-oxopyridazin-1(6H)-yl)] acetate (I), was added 10 ml of hydrazine hydrate. The mixture was placed in a pyrex tube which was then introduced into a Maxidigest MX 350 Prolabo microwave[<xref ref-type="bibr" rid="B4-molbank-2007-M531">4</xref>] monomode reactor and refluxed for 10 min on 60 w as irradiation power. After cooling, the product precipitates, and then is recristallised in absolute ethanol, yield : 80 % of (II) solid.  </p>
      <p>Melting point: 201-205&#xB0;C</p>
      <p>IR (KBr, cm<sup>-1</sup>): 3352(NH), 1682 , 1469 , 1622 (C = O) </p>
      <p><sup>1</sup>HNMR (300.14 MHz, CDCl<sub>3</sub>) &#x3B4; (ppm): 2.49 (s, 3H, CH<sub>3</sub>), 3.97 (s, 2H, CH<sub>2</sub>), 4.21 (s, 2H, NH<sub>2</sub>), 4.52 (s, 2H, CH<sub>2</sub>), 6.03 (s, 1H, H4), 7.53 (m, 4H, H aromatic), 9.24 (s, 2H, NH<sub>2</sub>).</p>
      <p><sup>13</sup>CNMR (75 MHz, CDCl<sub>3</sub>) &#x3B4; (ppm): 19.38 (CH<sub>3</sub>), 35.6 (CH<sub>2</sub>), 52.76 (CH<sub>2</sub>), 126.98 (CH aromatic), 128.85 (CH aromatic), 130.25 (CH aromatic), 130.68 (CH aromatic), 132.6 (CH aromatic), 134.54, 135.43, 144.93, 146.03, 160.31 (C=O), 167.16 (C=O).</p>
  </body>
  <back>
    <app-group>
    <app id="app1-molbank-2007-M531">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2007-M531-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M531-s001-mod.mol">
         <label>Supplementary File 1</label>
        </supplementary-material>
        <supplementary-material id="molbank-2007-M531-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M531-s001.mol">
         <label>Supplementary File 2</label>
     </supplementary-material>
    </app>
</app-group>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2007-M531">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wermuth</surname>
              <given-names>C.G.</given-names>
            </name>
            <name>
              <surname>Leclerc</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Melounov</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <source>Chim. Ther.</source>
          <year>1971</year>
          <volume>2</volume>
          <fpage>109</fpage>
        </citation>
      </ref>
      <ref id="B2-molbank-2007-M531">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laborit</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Wermuth</surname>
              <given-names>C.G.</given-names>
            </name>
            <name>
              <surname>Delbarre</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Chekler</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Baron</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Rosen Garten</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <source>AGRESSOLOGIE</source>
          <year>1965</year>
          <volume>6</volume>
          <fpage>415</fpage>
          <pub-id pub-id-type="pmid">5845998</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2007-M531">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bellasio</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Parravicini</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Testa</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <source>Il Farmaco Ed Sci.</source>
          <year>1969</year>
          <volume>11</volume>
          <fpage>919</fpage>
        </citation>
      </ref>
      <ref id="B4-molbank-2007-M531">
        <label>4.</label>
		<note>
		<p>(a)
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kappe</surname>
              <given-names>C.O.</given-names>
            </name>
            <name>
              <surname>Dallinger</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <source>Nature Reviews Drug Discovery</source>
          <year>2006</year>
          <volume>5</volume>
          <fpage>51</fpage>
        </citation> (b)
		<citation citation-type="journal">
          <person-group person-group-type="author">
		     <name>
              <surname>De la Hoz</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Diaz-Ortiz</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Moreno</surname>
              <given-names>A.</given-names>
            </name>
			</person-group>
			<source>Chem. Soc. Rev.</source>
			<year>2005</year>
          <volume>34</volume>
          <fpage>164</fpage>
		  </citation>
		</p>
		</note>
      </ref>
    </ref-list>
  </back>
</article>
